Home U.S. Global Health Policy Program

View the Latest: U.S. Global Health Policy

Filter

List Grid

151 - 160 of 398 Results

  • Donor Government Funding for International Family Planning Declines After Increasing the Previous Three Years

    News Release

    A new KFF analysis finds donor government support for global family planning efforts totaled US$1.40 billion in 2020, a decline of US$114 million compared to last year’s level of US$1.52 billion. This decline in donor funding was largely due to the decreased funding from the UK, family planning’s second largest donor after the US. The UK decline was partly due to the timing of disbursements, but also to the effect of the COVID-19 pandemic on…

  • Following an Early Period of High Demand, Vaccination for Children Ages 5-11 Has Significantly Slowed

    News Release

    As of December 5, 16.7% of 5-11 year-olds had received at least one COVID-19 vaccine dose with 4.3% of children reaching full vaccination, according to a new KFF analysis. After a short period of high demand, the rate of new vaccinations slowed significantly leading into the Thanksgiving holiday and has continued at the slower pace since. Vaccination efforts around the country continue to differ, with more than a 40 percentage point difference between the top…

  • An Update on Vaccine Roll-Out for 5-11 Year-olds in the U.S.

    Issue Brief

    This data note provides an analysis of COVID-19 vaccination rates among 5-11 year-old children across the states. Overall, we find wide variation in share of children who have received at least one dose of a COVID-19 vaccine across the states.

  • The U.S. Congress and Global Health: A Primer

    Report

    This primer provides an overview of congressional engagement in global health. It examines the structure of Congress and its role and key activities in global health. It then illustrates these by examining two global health examples: the creation and evolution of PEPFAR and the 2014/2015 Ebola outbreak in West Africa.

  • Rapid Home Tests for COVID-19: Issues with Availability and Access in the U.S.

    Issue Brief

    In this brief, we examine the various interrelated factors that have contributed to rapid home test scarcity in the U.S. There are several interrelated factors that impact the availability of rapid home COVID-19 tests. These range from the regulatory environment to the supply chain to federal investment and messaging to affordability.

  • Senate Appropriations Committee Releases FY 2022 State and Foreign Operations (SFOPs) and Labor Health and Human Services (Labor HHS) Appropriations Bills

    Fact Sheet

    The Senate Appropriations Committee released its FY 2022 State, Foreign Operations, and Related Programs (SFOPs) (links to bill and report) and Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) (links to bill and report) appropriations bills and accompanying reports on October 18, 2021. The SFOPs bill includes funding for U.S. global health programs at the State Department and the U.S. Agency for International Development (USAID), while the Labor HHS bill includes funding…

  • As PEPFAR Nears its Two-Decade Mark, New Analysis Finds That Mortality Declined Substantially in PEPFAR Countries Over the Course of the Program

    News Release

    A new KFF analysis finds the President's Emergency Plan for AIDS Relief (PEPFAR) program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003. The new analysis takes a closer look at PEPFAR’s health impact by assessing the all-cause mortality rate in 90 PEPFAR recipient countries compared to similar low-and middle-income countries. The all-cause mortality rate was 20% lower than expected had PEPFAR been absent. PEPFAR countries with higher…

  • Assessing PEPFAR’s Impact: Analysis of Mortality in PEPFAR Countries

    Issue Brief

    As the PEPFAR program approaches its two-decade mark, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.